These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3340205)

  • 1. Ireland's new biotechnology venture puts marketing first.
    Wenz C
    Nature; 1988 Feb; 331(6157):553. PubMed ID: 3340205
    [No Abstract]   [Full Text] [Related]  

  • 2. Newsmaker interview: Frank Gannon. Ireland's departing research chief on Irish and European science. Interview by John Travis.
    Gannon F
    Science; 2010 Sep; 329(5996):1139. PubMed ID: 20813930
    [No Abstract]   [Full Text] [Related]  

  • 3. Going green: Ireland.
    Smaglik P
    Nature; 2002 Mar; 416(6878):4-5. PubMed ID: 11907532
    [No Abstract]   [Full Text] [Related]  

  • 4. Education research: Academy cooperates in new venture.
    Welsh J
    Science; 1969 Jan; 163(3863):162-5. PubMed ID: 5762761
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomedical research. Australia pushes stem cell advantage.
    Dayton L
    Science; 2002 Jun; 296(5574):1779-81. PubMed ID: 12052925
    [No Abstract]   [Full Text] [Related]  

  • 6. Stem cell lines. NIH's list of 64 leaves questions.
    Holden C
    Science; 2001 Aug; 293(5535):1567. PubMed ID: 11533448
    [No Abstract]   [Full Text] [Related]  

  • 7. Institute of Health Services and Policy Research.
    Wysong P
    Clin Invest Med; 2004 Feb; 27(1):7-9. PubMed ID: 15061578
    [No Abstract]   [Full Text] [Related]  

  • 8. France. Will French science swallow Zerhouni's strong medicine?
    Enserink M
    Science; 2008 Nov; 322(5906):1312. PubMed ID: 19039109
    [No Abstract]   [Full Text] [Related]  

  • 9. Ireland embraces biotechnology.
    Canning S
    Nat Biotechnol; 2000 Mar; 18(3):273-5. PubMed ID: 10700138
    [No Abstract]   [Full Text] [Related]  

  • 10. Japan creeps toward proteomics.
    Saegusa A
    Nat Biotechnol; 2000 Jan; 18(1):16-7. PubMed ID: 10625377
    [No Abstract]   [Full Text] [Related]  

  • 11. Canada pours funds into health research.
    Spurgeon D
    Nature; 2001 Feb; 409(6820):549. PubMed ID: 11214286
    [No Abstract]   [Full Text] [Related]  

  • 12. Scripps to get less from Sandoz.
    Anderson C
    Science; 1994 May; 264(5162):1077. PubMed ID: 8178164
    [No Abstract]   [Full Text] [Related]  

  • 13. ATP under attack.
    Surendran A
    Nat Biotechnol; 2004 Apr; 22(4):477-8. PubMed ID: 15085806
    [No Abstract]   [Full Text] [Related]  

  • 14. Australia. Last-ditch effort to save center at vanguard of stem cell research.
    Finkel E
    Science; 2008 Oct; 322(5901):524-5. PubMed ID: 18948515
    [No Abstract]   [Full Text] [Related]  

  • 15. Finnish biotechnology--built on solid foundations.
    Lähteenmäki R
    Nature; 2002 Dec; 420(6916 Suppl):A34-5, A37, A39. PubMed ID: 12501125
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effectiveness casts first shadows across US industry.
    Waltz E
    Nat Biotechnol; 2009 Mar; 27(3):211-2. PubMed ID: 19270651
    [No Abstract]   [Full Text] [Related]  

  • 17. NSF puts big money into complex ecology.
    Macilwain C
    Nature; 2000 Oct; 407(6806):823. PubMed ID: 11057630
    [No Abstract]   [Full Text] [Related]  

  • 18. Japanese council urges reform of funding system.
    Triendl R
    Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomedical research. Looks can be deceptive.
    Casassus B
    Science; 2003 Jul; 301(5629):35. PubMed ID: 12843371
    [No Abstract]   [Full Text] [Related]  

  • 20. [The trends in the management reorganization of medical science under market economy conditions].
    Mattis ER; Ostapiuk SF
    Vestn Ross Akad Med Nauk; 1992; (11-12):61-3. PubMed ID: 1284228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.